Head‐to‐head: how many categories for grading urothelial carcinoma?

Abstract

Tumour grade is a critical prognostic parameter for guiding the management of patients with non‐muscle invasive bladder cancer. In 2004, the World Health Organisation (WHO) adopted a binary (low‐grade/high‐grade) grading system to replace the three‐tier (grades 1–3) system used to grade urothelial carcinoma since 1973. However, there is significant global variation in the grading of urothelial carcinoma. Some pathology and clinical guidelines recommend reporting of the WHO 1973 and 2004 grades in parallel, while others require reporting only of the WHO 2004 grade. This variation in pathology practice is clinically significant, because the two grading systems are not readily translatable. Some experts have proposed novel systems for grading urothelial carcinoma that involve splitting of the WHO 1973 and 2004 grade categories. The arguments for and against splitting urothelial carcinomas into two‐, three‐ and four‐grade categories are independently discussed by the three authors.